English

Evogene Ltd.

EDGAR

EVGN Report (type unavailable) · filed 2026-10-06

Annual consolidated revenue for 2025: about USD 3.853M, using the latest reported figures. The previous period, 2024, was about USD 5.577M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

3.85 million USD

2025 · USD

Exact inputs and evidence

Revenue: 3853000 USD Source

Operating margin

-364.24%

2025 · %

Exact inputs and evidence

Operating Income: -14034000 USD Source
Revenue: 3853000 USD Source

Operating cash flow

-13.5 million USD

2025 · USD

Exact inputs and evidence

Operating Cash Flow: -13502000 USD Source

Free cash flow

-13.6 million USD

2025 · USD

Exact inputs and evidence

Operating Cash Flow: -13502000 USD Source
Capital Expenditure: 135000 USD Source

Cash and cash equivalents: 13 million USD 2025-12-31 Source
Exact value

12956000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-06.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 10 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 10 of 11 periods available· newest 2025-12-31
Total liabilities: 3 of 11 periods available· newest 2025-12-31
Current assets: 10 of 11 periods available· newest 2025-12-31
Current liabilities: 10 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-30.9%

Prior period

USD 5.58 million

2024-01-01 – 2024-12-31
Current period

USD 3.85 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

3853000 − 5577000 = -1724000 USD

5577000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
3853000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Evogene Ltd. · 2025-12-31 Evogene Ltd. (edgar:1574565) Year-over-year change in Revenue: -1724000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3853000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#3998733 Filing: 000117891326001767 Input fundies:Revenue: 5577000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#4051207 Filing: 000117891326001767
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 8 million

Prior period

−USD 16.49 million

2024-01-01 – 2024-12-31
Current period

−USD 8.49 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-8485000 − -16485000 = 8000000 USD

-16485000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-8485000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Evogene Ltd. · 2025-12-31 Evogene Ltd. (edgar:1574565) Year-over-year change in Net income: 8000000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -8485000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#1771637 Filing: 000117891326001767 Input fundies:NetIncome: -16485000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#1772638 Filing: 000117891326001767
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 6.2 million

Prior period

−USD 19.7 million

2024-01-01 – 2024-12-31
Current period

−USD 13.5 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-13502000 − -19700000 = 6198000 USD

-19700000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-13502000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Evogene Ltd. · 2025-12-31 Evogene Ltd. (edgar:1574565) Year-over-year change in Operating cash flow: 6198000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13502000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2327928 Filing: 000117891326001767 Input fundies:OperatingCashFlow: -19700000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2328176 Filing: 000117891326001767
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-78.4%

Prior period

USD 626,000

2024-01-01 – 2024-12-31
Current period

USD 135,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

135000 − 626000 = -491000 USD

626000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
135000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Evogene Ltd. · 2025-12-31 Evogene Ltd. (edgar:1574565) Year-over-year change in Capital expenditure: -491000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 135000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2196685 Filing: 000117891326001767 Input fundies:CapitalExpenditure: 626000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2197925 Filing: 000117891326001767
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 3.85 million 100% of revenue
Cost of revenue USD 4.09 million 106% of revenue
Operating expenses USD 12.28 million 319% of revenue
Other operating costs Derived USD 1.51 million 39% of revenue
Operating income −USD 14.03 million −364% of revenue
Tax, interest and other Derived −USD 5.55 million −144% of revenue
Net income −USD 8.49 million −220% of revenue

Cash

Operating cash flow −USD 13.5 million −350% of revenue
Capital expenditure USD 135,000 3.5% of revenue
Free cash flow Derived −USD 13.64 million −354% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 422% of revenue.
2017 Operating loss: operating costs were 749% of revenue.
2018 Operating loss: operating costs were 1,244% of revenue.
2019 Operating loss: operating costs were 2,911% of revenue.
2020 Operating loss: operating costs were 2,486% of revenue.
2021 Operating loss: operating costs were 3,428% of revenue.
2022 Operating loss: operating costs were 1,708% of revenue.
2023 Operating loss: operating costs were 846% of revenue.
2024 Operating loss: operating costs were 437% of revenue.
2025 Operating loss: operating costs were 464% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	6540000	27629000 Derived	-21089000	-1497000 Derived	-19592000	-12501000 Derived	Source 2016-01-01 – 2016-12-31: 6540000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -21089000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -19592000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -11693000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 808000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	3381000	25328000 Derived	-21947000	-1109000 Derived	-20838000	-16519000 Derived	Source 2017-01-01 – 2017-12-31: 3381000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -21947000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -20838000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -15929000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 590000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	1747000	21736000 Derived	-19989000	769000 Derived	-20758000	-15535000 Derived	Source 2018-01-01 – 2018-12-31: 1747000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -19989000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -20758000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -15161000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 374000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	753000	21919000 Derived	-21166000	-3054000 Derived	-18112000	-18566000 Derived	Source 2019-01-01 – 2019-12-31: 753000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -21166000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -18112000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -17666000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 900000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	1040000	25854000 Derived	-24814000	-1440000 Derived	-23374000	-20196000 Derived	Source 2020-01-01 – 2020-12-31: 1040000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -24814000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -23374000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -19514000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 682000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	930000	31883000 Derived	-30953000	-3160000 Derived	-27793000	-25563000 Derived	Source 2021-01-01 – 2021-12-31: 930000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -30953000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -27793000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -24716000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 847000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	1675000	28616000 Derived	-26941000	-303000 Derived	-26638000	-24849000 Derived	Source 2022-01-01 – 2022-12-31: 1675000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -26941000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -26638000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -23678000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 1171000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	2982000	25213000 Derived	-22231000	1648000 Derived	-23879000	-22154000 Derived	Source 2023-01-01 – 2023-12-31: 2982000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -22231000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -23879000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -21577000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 577000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	5577000	24381000 Derived	-18804000	-2319000 Derived	-16485000	-20326000 Derived	Source 2024-01-01 – 2024-12-31: 5577000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -18804000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -16485000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -19700000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 626000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	3853000	17887000 Derived	-14034000	-5549000 Derived	-8485000	-13637000 Derived	Source 2025-01-01 – 2025-12-31: 3853000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -14034000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -8485000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -13502000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 135000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.9M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	6540000	Revenue: 6540000 Open source
20172017-12-31	Revenue	3381000	Revenue: 3381000 Open source
20182018-12-31	Revenue	1747000	Revenue: 1747000 Open source
20192019-12-31	Revenue	753000	Revenue: 753000 Open source
20202020-12-31	Revenue	1040000	Revenue: 1040000 Open source
20212021-12-31	Revenue	930000	Revenue: 930000 Open source
20222022-12-31	Revenue	1675000	Revenue: 1675000 Open source
20232023-12-31	Revenue	2982000	Revenue: 2982000 Open source
20242024-12-31	Revenue	5577000	Revenue: 5577000 Open source
20252025-12-31	Revenue	3853000	Revenue: 3853000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-30.9% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	-41.2%	Revenue: 6540000 Open source Revenue: 11129000 Open source
20172017-12-31	Year over year	-48.3%	Revenue: 3381000 Open source Revenue: 6540000 Open source
20182018-12-31	Year over year	-48.3%	Revenue: 1747000 Open source Revenue: 3381000 Open source
20192019-12-31	Year over year	-56.9%	Revenue: 753000 Open source Revenue: 1747000 Open source
20202020-12-31	Year over year	38.1%	Revenue: 1040000 Open source Revenue: 753000 Open source
20212021-12-31	Year over year	-10.6%	Revenue: 930000 Open source Revenue: 1040000 Open source
20222022-12-31	Year over year	80.1%	Revenue: 1675000 Open source Revenue: 930000 Open source
20232023-12-31	Year over year	78%	Revenue: 2982000 Open source Revenue: 1675000 Open source
20242024-12-31	Year over year	87%	Revenue: 5577000 Open source Revenue: 2982000 Open source
20252025-12-31	Year over year	-30.9%	Revenue: 3853000 Open source Revenue: 5577000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -364.2% 2025

Net margin -220.2% 2025

Free cash flow margin -353.9% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-322.5%	Operating Income: -21089000 Open source Revenue: 6540000 Open source
20172017-12-31	Operating margin	-649.1%	Operating Income: -21947000 Open source Revenue: 3381000 Open source
20182018-12-31	Operating margin	-1,144.2%	Operating Income: -19989000 Open source Revenue: 1747000 Open source
20192019-12-31	Operating margin	-2,810.9%	Operating Income: -21166000 Open source Revenue: 753000 Open source
20202020-12-31	Operating margin	-2,386%	Operating Income: -24814000 Open source Revenue: 1040000 Open source
20212021-12-31	Operating margin	-3,328.3%	Operating Income: -30953000 Open source Revenue: 930000 Open source
20222022-12-31	Operating margin	-1,608.4%	Operating Income: -26941000 Open source Revenue: 1675000 Open source
20232023-12-31	Operating margin	-745.5%	Operating Income: -22231000 Open source Revenue: 2982000 Open source
20242024-12-31	Operating margin	-337.2%	Operating Income: -18804000 Open source Revenue: 5577000 Open source
20252025-12-31	Operating margin	-364.2%	Operating Income: -14034000 Open source Revenue: 3853000 Open source
20162016-12-31	Net margin	-299.6%	Net Income: -19592000 Open source Revenue: 6540000 Open source
20172017-12-31	Net margin	-616.3%	Net Income: -20838000 Open source Revenue: 3381000 Open source
20182018-12-31	Net margin	-1,188.2%	Net Income: -20758000 Open source Revenue: 1747000 Open source
20192019-12-31	Net margin	-2,405.3%	Net Income: -18112000 Open source Revenue: 753000 Open source
20202020-12-31	Net margin	-2,247.5%	Net Income: -23374000 Open source Revenue: 1040000 Open source
20212021-12-31	Net margin	-2,988.5%	Net Income: -27793000 Open source Revenue: 930000 Open source
20222022-12-31	Net margin	-1,590.3%	Net Income: -26638000 Open source Revenue: 1675000 Open source
20232023-12-31	Net margin	-800.8%	Net Income: -23879000 Open source Revenue: 2982000 Open source
20242024-12-31	Net margin	-295.6%	Net Income: -16485000 Open source Revenue: 5577000 Open source
20252025-12-31	Net margin	-220.2%	Net Income: -8485000 Open source Revenue: 3853000 Open source
20162016-12-31	Free cash flow margin	-191.1%	Revenue: 6540000 Open source Operating Cash Flow: -11693000 Open source Capital Expenditure: 808000 Open source
20172017-12-31	Free cash flow margin	-488.6%	Revenue: 3381000 Open source Operating Cash Flow: -15929000 Open source Capital Expenditure: 590000 Open source
20182018-12-31	Free cash flow margin	-889.2%	Revenue: 1747000 Open source Operating Cash Flow: -15161000 Open source Capital Expenditure: 374000 Open source
20192019-12-31	Free cash flow margin	-2,465.6%	Revenue: 753000 Open source Operating Cash Flow: -17666000 Open source Capital Expenditure: 900000 Open source
20202020-12-31	Free cash flow margin	-1,941.9%	Revenue: 1040000 Open source Operating Cash Flow: -19514000 Open source Capital Expenditure: 682000 Open source
20212021-12-31	Free cash flow margin	-2,748.7%	Revenue: 930000 Open source Operating Cash Flow: -24716000 Open source Capital Expenditure: 847000 Open source
20222022-12-31	Free cash flow margin	-1,483.5%	Revenue: 1675000 Open source Operating Cash Flow: -23678000 Open source Capital Expenditure: 1171000 Open source
20232023-12-31	Free cash flow margin	-742.9%	Revenue: 2982000 Open source Operating Cash Flow: -21577000 Open source Capital Expenditure: 577000 Open source
20242024-12-31	Free cash flow margin	-364.5%	Revenue: 5577000 Open source Operating Cash Flow: -19700000 Open source Capital Expenditure: 626000 Open source
20252025-12-31	Free cash flow margin	-353.9%	Revenue: 3853000 Open source Operating Cash Flow: -13502000 Open source Capital Expenditure: 135000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.5M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-11693000	Operating Cash Flow: -11693000 Open source
20172017-12-31	Operating cash flow	-15929000	Operating Cash Flow: -15929000 Open source
20182018-12-31	Operating cash flow	-15161000	Operating Cash Flow: -15161000 Open source
20192019-12-31	Operating cash flow	-17666000	Operating Cash Flow: -17666000 Open source
20202020-12-31	Operating cash flow	-19514000	Operating Cash Flow: -19514000 Open source
20212021-12-31	Operating cash flow	-24716000	Operating Cash Flow: -24716000 Open source
20222022-12-31	Operating cash flow	-23678000	Operating Cash Flow: -23678000 Open source
20232023-12-31	Operating cash flow	-21577000	Operating Cash Flow: -21577000 Open source
20242024-12-31	Operating cash flow	-19700000	Operating Cash Flow: -19700000 Open source
20252025-12-31	Operating cash flow	-13502000	Operating Cash Flow: -13502000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -13.6M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-12501000	Operating Cash Flow: -11693000 Open source Capital Expenditure: 808000 Open source
20172017-12-31	Free cash flow	-16519000	Operating Cash Flow: -15929000 Open source Capital Expenditure: 590000 Open source
20182018-12-31	Free cash flow	-15535000	Operating Cash Flow: -15161000 Open source Capital Expenditure: 374000 Open source
20192019-12-31	Free cash flow	-18566000	Operating Cash Flow: -17666000 Open source Capital Expenditure: 900000 Open source
20202020-12-31	Free cash flow	-20196000	Operating Cash Flow: -19514000 Open source Capital Expenditure: 682000 Open source
20212021-12-31	Free cash flow	-25563000	Operating Cash Flow: -24716000 Open source Capital Expenditure: 847000 Open source
20222022-12-31	Free cash flow	-24849000	Operating Cash Flow: -23678000 Open source Capital Expenditure: 1171000 Open source
20232023-12-31	Free cash flow	-22154000	Operating Cash Flow: -21577000 Open source Capital Expenditure: 577000 Open source
20242024-12-31	Free cash flow	-20326000	Operating Cash Flow: -19700000 Open source Capital Expenditure: 626000 Open source
20252025-12-31	Free cash flow	-13637000	Operating Cash Flow: -13502000 Open source Capital Expenditure: 135000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

40.3% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2016-12-31	Liabilities / assets	Not reported	Total Assets: 95986000 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 77602000 Open source
2018-12-31	Liabilities / assets	Not reported	Total Assets: 58694000 Open source
2019-12-31	Liabilities / assets	Not reported	Total Assets: 71364000 Open source
2020-12-31	Liabilities / assets	Not reported	Total Assets: 71915000 Open source
2021-12-31	Liabilities / assets	Not reported	Total Assets: 76304000 Open source
2022-12-31	Liabilities / assets	Not reported	Total Assets: 56126000 Open source
20232023-12-31	Liabilities / assets	43.9%	Total Liabilities: 22416000 Open source Total Assets: 51101000 Open source
20242024-12-31	Liabilities / assets	62.8%	Total Liabilities: 25026000 Open source Total Assets: 39864000 Open source
20252025-12-31	Liabilities / assets	40.3%	Total Liabilities: 8071000 Open source Total Assets: 20046000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.54× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	17.13×	Current Assets: 89490000 Open source Current Liabilities: 5225000 Open source
20172017-12-31	Current assets / current liabilities	15.61×	Current Assets: 72791000 Open source Current Liabilities: 4664000 Open source
20182018-12-31	Current assets / current liabilities	10.22×	Current Assets: 55488000 Open source Current Liabilities: 5431000 Open source
20192019-12-31	Current assets / current liabilities	8.53×	Current Assets: 49027000 Open source Current Liabilities: 5746000 Open source
20202020-12-31	Current assets / current liabilities	5.36×	Current Assets: 51823000 Open source Current Liabilities: 9676000 Open source
20212021-12-31	Current assets / current liabilities	8.27×	Current Assets: 56890000 Open source Current Liabilities: 6882000 Open source
20222022-12-31	Current assets / current liabilities	6.71×	Current Assets: 37751000 Open source Current Liabilities: 5625000 Open source
20232023-12-31	Current assets / current liabilities	4.96×	Current Assets: 34469000 Open source Current Liabilities: 6944000 Open source
20242024-12-31	Current assets / current liabilities	1.15×	Current Assets: 21589000 Open source Current Liabilities: 18695000 Open source
20252025-12-31	Current assets / current liabilities	4.54×	Current Assets: 15631000 Open source Current Liabilities: 3444000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 19.59 million Exact value Exact value: -19592000 USD 2016-01-01 – 2016-12-31: -19592000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Evogene Ltd. · 2016-12-31 Evogene Ltd. (edgar:1574565) Net Income: -19592000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19592000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891319001243/evgn-20181231.xml#225322 Filing: 000117891319001243 The citation records this snapshot. The page link may show a newer release later.	−USD 11.69 million Exact value Exact value: -11693000 USD 2016-01-01 – 2016-12-31: -11693000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Evogene Ltd. · 2016-12-31 Evogene Ltd. (edgar:1574565) Operating Cash Flow: -11693000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11693000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891319001243/evgn-20181231.xml#180933 Filing: 000117891319001243 The citation records this snapshot. The page link may show a newer release later.	USD 808,000 Exact value Exact value: 808000 USD 2016-01-01 – 2016-12-31: 808000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Evogene Ltd. · 2016-12-31 Evogene Ltd. (edgar:1574565) Capital Expenditure: 808000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 808000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891319001243/evgn-20181231.xml#181746 Filing: 000117891319001243 The citation records this snapshot. The page link may show a newer release later.	−USD 12.5 million Calculation and evidence -11693000 − 808000 USD Exact free cash flow: -12501000 USD 2016-01-01 – 2016-12-31: -11693000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 808000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Evogene Ltd. · 2016-12-31 Evogene Ltd. (edgar:1574565) Free cash flow: -12501000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11693000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891319001243/evgn-20181231.xml#180933 Filing: 000117891319001243 Input fundies:CapitalExpenditure: 808000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891319001243/evgn-20181231.xml#181746 Filing: 000117891319001243 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 20.84 million Exact value Exact value: -20838000 USD 2017-01-01 – 2017-12-31: -20838000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Evogene Ltd. · 2017-12-31 Evogene Ltd. (edgar:1574565) Net Income: -20838000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20838000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891320001229/evgn-20191231.xml#268435 Filing: 000117891320001229 The citation records this snapshot. The page link may show a newer release later.	−USD 15.93 million Exact value Exact value: -15929000 USD 2017-01-01 – 2017-12-31: -15929000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Evogene Ltd. · 2017-12-31 Evogene Ltd. (edgar:1574565) Operating Cash Flow: -15929000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15929000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891320001229/evgn-20191231.xml#227442 Filing: 000117891320001229 The citation records this snapshot. The page link may show a newer release later.	USD 590,000 Exact value Exact value: 590000 USD 2017-01-01 – 2017-12-31: 590000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Evogene Ltd. · 2017-12-31 Evogene Ltd. (edgar:1574565) Capital Expenditure: 590000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 590000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891320001229/evgn-20191231.xml#227991 Filing: 000117891320001229 The citation records this snapshot. The page link may show a newer release later.	−USD 16.52 million Calculation and evidence -15929000 − 590000 USD Exact free cash flow: -16519000 USD 2017-01-01 – 2017-12-31: -15929000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 590000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Evogene Ltd. · 2017-12-31 Evogene Ltd. (edgar:1574565) Free cash flow: -16519000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15929000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891320001229/evgn-20191231.xml#227442 Filing: 000117891320001229 Input fundies:CapitalExpenditure: 590000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891320001229/evgn-20191231.xml#227991 Filing: 000117891320001229 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 20.76 million Exact value Exact value: -20758000 USD 2018-01-01 – 2018-12-31: -20758000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Evogene Ltd. · 2018-12-31 Evogene Ltd. (edgar:1574565) Net Income: -20758000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20758000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891321001263/evgn-20201231.xml#300486 Filing: 000117891321001263 The citation records this snapshot. The page link may show a newer release later.	−USD 15.16 million Exact value Exact value: -15161000 USD 2018-01-01 – 2018-12-31: -15161000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Evogene Ltd. · 2018-12-31 Evogene Ltd. (edgar:1574565) Operating Cash Flow: -15161000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15161000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891321001263/evgn-20201231.xml#259663 Filing: 000117891321001263 The citation records this snapshot. The page link may show a newer release later.	USD 374,000 Exact value Exact value: 374000 USD 2018-01-01 – 2018-12-31: 374000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Evogene Ltd. · 2018-12-31 Evogene Ltd. (edgar:1574565) Capital Expenditure: 374000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 374000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891321001263/evgn-20201231.xml#260212 Filing: 000117891321001263 The citation records this snapshot. The page link may show a newer release later.	−USD 15.54 million Calculation and evidence -15161000 − 374000 USD Exact free cash flow: -15535000 USD 2018-01-01 – 2018-12-31: -15161000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 374000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Evogene Ltd. · 2018-12-31 Evogene Ltd. (edgar:1574565) Free cash flow: -15535000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15161000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891321001263/evgn-20201231.xml#259663 Filing: 000117891321001263 Input fundies:CapitalExpenditure: 374000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891321001263/evgn-20201231.xml#260212 Filing: 000117891321001263 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 18.11 million Exact value Exact value: -18112000 USD 2019-01-01 – 2019-12-31: -18112000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Evogene Ltd. · 2019-12-31 Evogene Ltd. (edgar:1574565) Net Income: -18112000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18112000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891322001337/zk2227542.htm#1596499 Filing: 000117891322001337 The citation records this snapshot. The page link may show a newer release later.	−USD 17.67 million Exact value Exact value: -17666000 USD 2019-01-01 – 2019-12-31: -17666000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Evogene Ltd. · 2019-12-31 Evogene Ltd. (edgar:1574565) Operating Cash Flow: -17666000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17666000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891322001337/zk2227542.htm#1932655 Filing: 000117891322001337 The citation records this snapshot. The page link may show a newer release later.	USD 900,000 Exact value Exact value: 900000 USD 2019-01-01 – 2019-12-31: 900000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Evogene Ltd. · 2019-12-31 Evogene Ltd. (edgar:1574565) Capital Expenditure: 900000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 900000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891322001337/zk2227542.htm#1944002 Filing: 000117891322001337 The citation records this snapshot. The page link may show a newer release later.	−USD 18.57 million Calculation and evidence -17666000 − 900000 USD Exact free cash flow: -18566000 USD 2019-01-01 – 2019-12-31: -17666000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 900000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Evogene Ltd. · 2019-12-31 Evogene Ltd. (edgar:1574565) Free cash flow: -18566000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17666000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891322001337/zk2227542.htm#1932655 Filing: 000117891322001337 Input fundies:CapitalExpenditure: 900000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891322001337/zk2227542.htm#1944002 Filing: 000117891322001337 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 23.37 million Exact value Exact value: -23374000 USD 2020-01-01 – 2020-12-31: -23374000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Evogene Ltd. · 2020-12-31 Evogene Ltd. (edgar:1574565) Net Income: -23374000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23374000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891323001224/zk2329437.htm#1715557 Filing: 000117891323001224 The citation records this snapshot. The page link may show a newer release later.	−USD 19.51 million Exact value Exact value: -19514000 USD 2020-01-01 – 2020-12-31: -19514000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Evogene Ltd. · 2020-12-31 Evogene Ltd. (edgar:1574565) Operating Cash Flow: -19514000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19514000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891323001224/zk2329437.htm#2191694 Filing: 000117891323001224 The citation records this snapshot. The page link may show a newer release later.	USD 682,000 Exact value Exact value: 682000 USD 2020-01-01 – 2020-12-31: 682000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Evogene Ltd. · 2020-12-31 Evogene Ltd. (edgar:1574565) Capital Expenditure: 682000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 682000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891323001224/zk2329437.htm#2203753 Filing: 000117891323001224 The citation records this snapshot. The page link may show a newer release later.	−USD 20.2 million Calculation and evidence -19514000 − 682000 USD Exact free cash flow: -20196000 USD 2020-01-01 – 2020-12-31: -19514000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 682000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Evogene Ltd. · 2020-12-31 Evogene Ltd. (edgar:1574565) Free cash flow: -20196000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19514000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891323001224/zk2329437.htm#2191694 Filing: 000117891323001224 Input fundies:CapitalExpenditure: 682000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891323001224/zk2329437.htm#2203753 Filing: 000117891323001224 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 27.79 million Exact value Exact value: -27793000 USD 2021-01-01 – 2021-12-31: -27793000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Evogene Ltd. · 2021-12-31 Evogene Ltd. (edgar:1574565) Net Income: -27793000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27793000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891324001137/zk2431172.htm#1729146 Filing: 000117891324001137 The citation records this snapshot. The page link may show a newer release later.	−USD 24.72 million Exact value Exact value: -24716000 USD 2021-01-01 – 2021-12-31: -24716000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Evogene Ltd. · 2021-12-31 Evogene Ltd. (edgar:1574565) Operating Cash Flow: -24716000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24716000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891324001137/zk2431172.htm#2175598 Filing: 000117891324001137 The citation records this snapshot. The page link may show a newer release later.	USD 847,000 Exact value Exact value: 847000 USD 2021-01-01 – 2021-12-31: 847000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Evogene Ltd. · 2021-12-31 Evogene Ltd. (edgar:1574565) Capital Expenditure: 847000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 847000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891324001137/zk2431172.htm#2187552 Filing: 000117891324001137 The citation records this snapshot. The page link may show a newer release later.	−USD 25.56 million Calculation and evidence -24716000 − 847000 USD Exact free cash flow: -25563000 USD 2021-01-01 – 2021-12-31: -24716000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 847000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Evogene Ltd. · 2021-12-31 Evogene Ltd. (edgar:1574565) Free cash flow: -25563000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24716000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891324001137/zk2431172.htm#2175598 Filing: 000117891324001137 Input fundies:CapitalExpenditure: 847000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891324001137/zk2431172.htm#2187552 Filing: 000117891324001137 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 26.64 million Exact value Exact value: -26638000 USD 2022-01-01 – 2022-12-31: -26638000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Evogene Ltd. · 2022-12-31 Evogene Ltd. (edgar:1574565) Net Income: -26638000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26638000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891325001092/zk2532892.htm#1821599 Filing: 000117891325001092 The citation records this snapshot. The page link may show a newer release later.	−USD 23.68 million Exact value Exact value: -23678000 USD 2022-01-01 – 2022-12-31: -23678000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Evogene Ltd. · 2022-12-31 Evogene Ltd. (edgar:1574565) Operating Cash Flow: -23678000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23678000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891325001092/zk2532892.htm#2251237 Filing: 000117891325001092 The citation records this snapshot. The page link may show a newer release later.	USD 1.17 million Exact value Exact value: 1171000 USD 2022-01-01 – 2022-12-31: 1171000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Evogene Ltd. · 2022-12-31 Evogene Ltd. (edgar:1574565) Capital Expenditure: 1171000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1171000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891325001092/zk2532892.htm#2262889 Filing: 000117891325001092 The citation records this snapshot. The page link may show a newer release later.	−USD 24.85 million Calculation and evidence -23678000 − 1171000 USD Exact free cash flow: -24849000 USD 2022-01-01 – 2022-12-31: -23678000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1171000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Evogene Ltd. · 2022-12-31 Evogene Ltd. (edgar:1574565) Free cash flow: -24849000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23678000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891325001092/zk2532892.htm#2251237 Filing: 000117891325001092 Input fundies:CapitalExpenditure: 1171000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891325001092/zk2532892.htm#2262889 Filing: 000117891325001092 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 23.88 million Exact value Exact value: -23879000 USD 2023-01-01 – 2023-12-31: -23879000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Evogene Ltd. · 2023-12-31 Evogene Ltd. (edgar:1574565) Net Income: -23879000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23879000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#1773660 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.	−USD 21.58 million Exact value Exact value: -21577000 USD 2023-01-01 – 2023-12-31: -21577000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Evogene Ltd. · 2023-12-31 Evogene Ltd. (edgar:1574565) Operating Cash Flow: -21577000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21577000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2188127 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.	USD 577,000 Exact value Exact value: 577000 USD 2023-01-01 – 2023-12-31: 577000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Evogene Ltd. · 2023-12-31 Evogene Ltd. (edgar:1574565) Capital Expenditure: 577000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 577000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2199163 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.	−USD 22.15 million Calculation and evidence -21577000 − 577000 USD Exact free cash flow: -22154000 USD 2023-01-01 – 2023-12-31: -21577000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 577000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Evogene Ltd. · 2023-12-31 Evogene Ltd. (edgar:1574565) Free cash flow: -22154000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21577000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2188127 Filing: 000117891326001767 Input fundies:CapitalExpenditure: 577000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2199163 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 16.49 million Exact value Exact value: -16485000 USD 2024-01-01 – 2024-12-31: -16485000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Evogene Ltd. · 2024-12-31 Evogene Ltd. (edgar:1574565) Net Income: -16485000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16485000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#1772638 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.	−USD 19.7 million Exact value Exact value: -19700000 USD 2024-01-01 – 2024-12-31: -19700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Evogene Ltd. · 2024-12-31 Evogene Ltd. (edgar:1574565) Operating Cash Flow: -19700000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19700000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2328176 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.	USD 626,000 Exact value Exact value: 626000 USD 2024-01-01 – 2024-12-31: 626000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Evogene Ltd. · 2024-12-31 Evogene Ltd. (edgar:1574565) Capital Expenditure: 626000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 626000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2197925 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.	−USD 20.33 million Calculation and evidence -19700000 − 626000 USD Exact free cash flow: -20326000 USD 2024-01-01 – 2024-12-31: -19700000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 626000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Evogene Ltd. · 2024-12-31 Evogene Ltd. (edgar:1574565) Free cash flow: -20326000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19700000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2328176 Filing: 000117891326001767 Input fundies:CapitalExpenditure: 626000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2197925 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 8.49 million Exact value Exact value: -8485000 USD 2025-01-01 – 2025-12-31: -8485000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Evogene Ltd. · 2025-12-31 Evogene Ltd. (edgar:1574565) Net Income: -8485000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8485000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#1771637 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.	−USD 13.5 million Exact value Exact value: -13502000 USD 2025-01-01 – 2025-12-31: -13502000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Evogene Ltd. · 2025-12-31 Evogene Ltd. (edgar:1574565) Operating Cash Flow: -13502000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13502000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2327928 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.	USD 135,000 Exact value Exact value: 135000 USD 2025-01-01 – 2025-12-31: 135000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Evogene Ltd. · 2025-12-31 Evogene Ltd. (edgar:1574565) Capital Expenditure: 135000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 135000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2196685 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.	−USD 13.64 million Calculation and evidence -13502000 − 135000 USD Exact free cash flow: -13637000 USD 2025-01-01 – 2025-12-31: -13502000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 135000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Evogene Ltd. · 2025-12-31 Evogene Ltd. (edgar:1574565) Free cash flow: -13637000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:35:06Z Snapshot: 079d0f50457f868daf9525765009d9a75617199ada96241f0f1d2edf63088046 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1574565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13502000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2327928 Filing: 000117891326001767 Input fundies:CapitalExpenditure: 135000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1574565/000117891326001767/zk2634882.htm#2196685 Filing: 000117891326001767 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

289 filings · 1,026 latest values · 1,026 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001574565, 1574565, EVGN, edgar:1574565

Also known as EVOGENE LTD., Evogene Ltd.

Evogene Ltd.

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation